Also, mutations and rearrangements affecting PTEN, PI3K family, and MTOR genes, the key participants in the PI3K/AKT/mTOR signaling axis, were more frequent in IDH—wildtype glioblastoma (80%) compared with LGG (38%). This evidence concerns the gene IDH1 and glioblastoma.